§ 13F · FUND PROFILE
RA CAPITAL MANAGEMENT, L.P..
AUM · $11.5B (13F)Positions · 85Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$4.5B deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED AUG 14, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | ASND | ASCENDIS PHARMA A/S | 10.28M | $2.7B | 23.8% | NEW |
| 2 | PBLS | PARABILIS MEDICINES INC | 28.93M | $792M | 6.9% | NEW |
| 3 | RYTM | RHYTHM PHARMACEUTICALS INC | 6.67M | $740M | 6.4% | ±0% |
| 4 | PCVX | VAXCYTE INC | 11.47M | $667M | 5.8% | ±0% |
| 5 | SION | SIONNA THERAPEUTICS INC | 9.91M | $436M | 3.8% | ±0% |
| 6 | TYRA | TYRA BIOSCIENCES INC | 12.20M | $390M | 3.4% | ±0% |
| 7 | EWTX | EDGEWISE THERAPEUTICS INC | 8.39M | $341M | 3.0% | −20% |
| 8 | NAMS | NEWAMSTERDAM PHARMA CO NV | 9.55M | $324M | 2.8% | ±0% |
| 9 | COAG | HEMAB THERAPEUTICS HOLDINGS | 7.81M | $287M | 2.5% | NEW |
| 10 | SEPN | SEPTERNA INC | 7.00M | $234M | 2.0% | ±0% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE RA SIGNAL
AC read
RA CAPITAL MANAGEMENT, L.P. is a Other fund managing $11.5 billion in assets. The fund runs a portfolio of 85 positions.
Read the full dossier →